Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice
about
A role for regulatory T cells in a murine model of epicutaneous toluene diisocyanate sensitizationMiRNA in atopic dermatitisImmunoregulatory molecules are master regulators of inflammation during the immune responsemiR-155: A Novel Target in Allergic AsthmaSurfactant protein D-mediated decrease of allergen-induced inflammation is dependent upon CTLA4.Role of T cell co-stimulation in murine models of allergic asthma.Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.Genes of tolerance.Mouse models of global airway allergy: what have we learned and what should we do next?The periarterial space in the lung: its important role in lung edema, transplantation, and microbial or allergic inflammation.Atopy, asthma, and experimental approaches based on the linear model of T cell maturation.Advances in allergen-specific immunotherapy.T regulatory cells in allergen-specific immunotherapy.Co-stimulatory molecules as potential targets for therapeutic intervention in allergic airway disease.Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells.Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.Experimental advances in understanding allergic airway inflammation.Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphylococcus aureus enterotoxin B.Progesterone increases airway eosinophilia and hyper-responsiveness in a murine model of allergic asthma.Functional polymorphism in CTLA4 gene influences the response to therapy with inhaled corticosteroids in Slovenian children with atopic asthma.The immune checkpoint molecule VISTA regulates allergen-specific Th2-mediated immune responses.Blockade of CTLA-4 promotes airway inflammation in naive mice exposed to aerosolized allergen but fails to prevent inhalation tolerance.Interaction of maternal atopy, CTLA-4 gene polymorphism and gender on antenatal immunoglobulin E production.Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma.Selective nasal allergen provocation induces substance P-mediated bronchial hyperresponsiveness.ACE gene polymorphism might disclose why some Taiwanese children with allergic rhinitis develop asthma symptoms but others do not.Trichloroethylene-induced hypersensitivity dermatitis was associated with hepatic metabolic enzyme genes and immune-related genesThe CTLA-4 +49 A/G and -318 C/T polymorphisms and susceptibility to asthma: a meta-analysisRole for CTLA-4 but not CD25+ T cells during Schistosoma mansoni infection of miceCTLA-4 regulates allergen response by modulating GATA-3 protein level per cellThe levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthmaCytotoxic T-lymphocyte antigen-4 inhibits GATA-3 but not T-bet mRNA expression during T helper cell differentiationIncreased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthmaCTLA-4 blockade inhibits induction of Helicobacter pylori-associated gastritis in mice
P2860
Q26345262-1A3530FB-E1F2-45DE-8368-4E7B57B891B6Q26741930-6770F45B-116F-4994-ADC3-A0604C70762EQ27022027-5FF5BEAB-60CD-48CA-BB42-FDA93A11ED17Q28077478-B777E949-5A2D-4EBA-ABBA-C3A887363C4EQ34001979-9B3A30CB-CFF7-4364-AB30-4FC07B423214Q35628016-A3AA3E0C-9625-419B-80A8-DBD60571D911Q35762746-C6F2AF83-F24E-4A64-BF65-5013685B3DE1Q35855013-C6ABC083-E786-47B9-9F95-29B5A3B571C4Q35855017-C2A6FF69-B53D-483D-BD81-0FF721DF99C1Q35997735-25F3E5E3-AEB3-4A45-8210-5633FA3B1889Q36008723-BB984CFE-FC78-43AE-B0F4-A769BA94164AQ36150445-9E403F3E-7230-4F99-B3A6-609E3DB3A198Q36327399-DB98A417-6C14-43DB-9259-2976382D7720Q36360561-3C5C12BC-41D7-4C23-966A-854B9F6A3BD8Q36429815-4A6CEB65-2BAA-4BCE-AC22-0C9DD7E44999Q36515366-F0EB2C8B-8AFF-4545-92BF-8AF7F8377A57Q37567936-18B13CCB-DE55-4B92-9C3D-6676F2F5ED0DQ38070582-468D6876-33B4-430A-BE57-7A0FE07CF406Q44131379-7DFF9406-23FA-4FAB-BA6B-FFCE1AB4E50FQ44602481-F1374F3A-EE57-49FB-B148-69155D6D3B25Q45713818-56580366-8F83-4C24-9A36-AB95E27EF678Q47673859-184F6A82-6820-4989-9C75-AC7AA1F2273FQ47685700-D7D87C74-071A-4A6D-8139-BF581F0315F1Q51755822-09EEE940-AC6E-4017-9D7E-460509E3C80BQ52008756-81213CD5-F7DF-4D38-94FE-89FBD4ED52B8Q53319380-B33CA93D-8958-41FF-A457-95BB591C0304Q53595962-7CBFBC6D-C1B2-48D1-AC3C-9F65EA0F52ECQ56895359-1D1BDF07-7FA8-4C55-A16D-EED3F5BD1FC4Q56897986-B4B51548-E527-4D3D-BEBB-C5B5071609D8Q56901349-9B59145D-B94E-4206-9938-A5ECD7ABA583Q56901422-E24EDD01-4FC7-42C3-9095-7F5CC3B03643Q56901462-2FB524C2-2262-44EA-A932-516F8C7F1991Q56902320-89EF9746-E322-45B1-88CD-D2E04BA8F5B5Q56902741-8B02358B-6621-4D66-B2DF-298D1F5FCF68Q56903604-7B6333E5-CD16-4B15-8ED1-D23071E3B984
P2860
Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice
description
im Februar 2002 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2002
@uk
name
Blockade of CTLA-4 enhances al ...... n genetically predisposed mice
@en
Blockade of CTLA-4 enhances al ...... n genetically predisposed mice
@nl
type
label
Blockade of CTLA-4 enhances al ...... n genetically predisposed mice
@en
Blockade of CTLA-4 enhances al ...... n genetically predisposed mice
@nl
prefLabel
Blockade of CTLA-4 enhances al ...... n genetically predisposed mice
@en
Blockade of CTLA-4 enhances al ...... n genetically predisposed mice
@nl
P2093
P2860
P1476
Blockade of CTLA-4 enhances al ...... n genetically predisposed mice
@en
P2093
Ahmad Kasran
Jan L Ceuppens
Lieve Coorevits
Lutgart Overbergh
Peter Vandenberghe
Peter W Hellings
P2860
P304
P356
10.1002/1521-4141(200202)32:2<585::AID-IMMU585>3.0.CO;2-U
P407
P577
2002-02-01T00:00:00Z